To develop insoluble Sn2+ complexes for the preparation of 99mTc radiopharmaceuticals, the adsorption of Sn2+ to macroreticular chelating ion exchange resins having various functional groups was investigated. Among them, a resin containing aminophosphonic acid groups showed a high adsorption capacit
Hydroxamamide as a chelating moiety for the preparation of 99mTc radiopharmaceuticals—II. The 99mTc complexes of hydroxamanide derivatives
✍ Scribed by M. Nakayama; H. Saigo; A. Koda; K. Ozeki; K. Harada; A. Sugii; S. Tomiguchi; A. Kojima; M. Hara; R. Nakashima; Y. Ohyama; M. Takahashi; J. Takata; Y. Karube
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 486 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0969-8043
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A freeze dried kit formulation for the preparation of 999c-[V]-DMS complex was developed, requiring a single step labeling procedure. Methods of analysis were also developed permitting identification of radiochemical impurities which may be resent in radiopharmaceutical solution. FjgmTc-[V]-DMS prep
An improved method for the preparation of 99mTc-radiopharmaceuticals containing the TEN multiple bond, in sterile and apyrogen conditions, is described. This method is based on the reaction of [99mTc]pertechnetate with ligands derived from S-methyl dithiocarbazate [H2N--N(R)~C(=S)SCH 3 (R = H, CH3]
## Abstract A novel and efficient method for preparing ^99m^Tc‐complexes of radiopharmaceuticals has been developed by reacting [^99m^Tc]pertechnetate with a ligand in the presence of borohydride exchange resin (BER) as a reducing agent. The latter is stable over a wide range of pH (2–11) and thus
99m Tc-EDDA-HYNIC-D-Phe 1 ,Tyr 3 ]-Octreotide ( 99m Tc-EDDA/HYNIC-TOC) is a promising new radiopharmaceutical with the potential to replace [ 111 In-DTPA-D-Phe 1 ]-Octreotide ( 111 In-DTPA-OCT) as the radiopharmaceutical for somatostatin receptor scintigraphy due to the advantage of improved image